 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Athersys, Inc. is a biotechnology company, which focuses on the field of regenerative medicine. It engages in the discovery and development of therapies designed to extend and enhance the quality of human life. The firm offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas. The company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Current Price	$0.9741
Prev Close	$0.98
Open	$0.99
Dividend Yield	0.00%
50-Day Moving Average	$0.9628
Beta	1.13
Avg. Volume	101,383.73
PE Ratio	-0.21

52-Week High	$10.50
52-Week Low	$0.5031
Market Capitalization	$20.45M
EPS	-$4.69
Price to Book	-0.58
Revenue Per Employee	$100,541.67
Enterprise Value/EBITDA	-0.46

ATHX Athersys Inc

About

Feed

Fundamentals

News